Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 3"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+3%22&lookfor=%22Coronavirus+Infections%22&type=Subject
PubPharm (227)
1
A Study of Baricitinib (LY3009104) in Children With COVID-19 : A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients From 1 Year to Less Than 18 Years Old Hospitalized With COVID-19
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Study of MK-4482 for Prevention of Coronavirus Disease 2019 (COVID-19) in Adults (MK-4482-013) : A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-4482 for the Prevention of COVID-19 (Laboratory-confirmed SARS-CoV-2 Infection With Symptoms) in Adults Residing With a Person With COVID-19
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial : Anti-Coronavirus Therapies to Prevent Progression of COVID-19, a Randomized Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076) : A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
5
Trial of Treatments for COVID-19 in Hospitalized Adults : Multi-centre, Adaptive, Randomized Trial of the Safety and Efficacy of Treatments of COVID-19 in Hospitalized Adults
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
6
Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects : Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
7
Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients : Multicenter Double-blind Placebo-controlled Parallel-group Randomized Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
8
A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection : A Multicenter, Randomized, Placebo-Controlled, Pragmatic Phase 3 Study Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic COVID-19 Infection
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
9
Clinical Study of Recombinant Novel Coronavirus(COVID-19) Vaccine (CHO Cell) Combined With Influenza Vaccine : Clinical Study on Immunogenicity and Safety of Recombinant Novel Coronavirus(COVID-19)Vaccine (CHO Cell) Combined With Tetravalent Influenza Virus Lysis Vaccine in People Aged 18 Years and Over
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID) : PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RUXOLITINIB IN PATIENTS WITH COVID-19 ASSOCIATED CYTOKINE STORM (RUXCOVID)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 3
Medienart
227
Aufsätze
227
E-Artikel
227
E-Ressourcen
Zeitschriftentitel
150
WHO International Clinical Trials Registry Plat...
77
ClinicalTrials.gov
Thema
227
610
Phase: Phase 3
227
Study Type: Interventional
77
Coronavirus Infections
77
Recruitment Status: Not yet recruiting
58
Recruitment Status: Authorised-recruitment may ...
32
Recruitment Status: Completed
31
COVID-19
26
Recruitment Status: Recruiting
20
Medical Condition: COVID-19 MedDRA version: 23....
18
Recruitment Status: Terminated
16
Medical Condition: Coronavirus disease 2019 (CO...
16
Medical Condition: Coronavirus disease 2019 (CO...
15
Severe Acute Respiratory Syndrome
14
Medical Condition: -B342 Coronavirus infection,...
12
Medical Condition: COVID-19 MedDRA version: 23....
10
Medical Condition: COVID-19 (Coronavirus Diseas...
10
Medical Condition: COVID-19 infection MedDRA ve...
9
Communicable Diseases
9
Infections
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2024
35
2023
44
2022
68
2021
77
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
223
Englisch
4
Unbestimmt
Haven't found what you're looking for?
Wird geladen...